Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: Anesth Analg. 2021 Mar 1;132(3):836–845. doi: 10.1213/ANE.0000000000005347

Table 3 –

Comparison of incidental and non-incidental thrombocytopenia according to patient anemia status*

Incidental TCP
Non-incidental TCP
Interaction P Estimate (95% CI) P Estimate (95% CI) P
Hospital length of stay
 Non-anemic patients 0.042 1.11 (1.00, 1.22) 0.042 0.98 (0.92, 1.05) 0.583
 Anemic patients 0.145 1.00 (0.93, 1.08) 0.949 1.07 (1.02, 1.13) 0.010
Perioperative transfusion
 Non-anemic patients 0.048 2.44 (1.66, 3.60) <.001 3.83 (3.06, 4.79) <.001
 Anemic patients <.001 1.73 (1.34, 2.22) <.001 3.18 (2.66, 3.80) <.001
Re-operation within 72 hours
 Non-anemic patients 0.130 0.24 (0.03, 1.69) 0.151 1.15 (0.65, 2.01) 0.633
 Anemic patients 0.636 1.41 (0.83, 2.41) 0.201 1.21 (0.82, 1.78) 0.328
ICU admission within 24 hours
 Non-anemic patients 0.862 1.62 (0.97, 2.69) 0.065 1.53 (1.11, 2.11) 0.009
 Anemic patients 0.876 0.91 (0.59, 1.40) 0.658 0.94 (0.71, 1.27) 0.702
*

Results are from multivariable linear or logistic regression adjusting for age, sex, ASA physical status, procedure type, anesthesia type, history of cancer, lymphoma, leukemia, liver disease, renal disease, MI, CHF, stroke, pre-operative antiplatelet therapy, and pre-operative anticoagulant. The interaction p-value tests for equality in effect of incidental and non-incidental TCP in the given patient population.

Hospital length of stay is modelled on the log scale and estimates are for the multiplicative increase in geometric mean associated with TCP in the given patient population.

Estimates are odds ratios for categorical variables and represent the increased risk of the given outcome associated with TCP in the given patient population.